Dr. David Elzi will present the poster “Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” at the UMASS RNA Therapeutics Symposium

PUBLISHED ON June 8, 2021

Dr. Elzi will present his poster “Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” at the University of Massachusetts RNA Therapeutics Symposium: From Concept to Clinic, June 23-25, 2021. Dr. Elzi’s live presentation will be Wednesday June 23, from 3:30PM-4:15PM EDT.

read more

Dr. Lydia Bederka to present at CYTO2020

PUBLISHED ON July 23, 2020

Dr. Lydia Bederka will present the poster “Sputum-Derived Cellular Profiles Produced by Flow Cytometric Analysis” (Poster #P223) at the International Society for the Advancement of Cytometry conference, CYTO2020 on August 4-5, 2020.  Cytometry is the quantitative analysis of cells and cell systems and is used in the analysis of sputum for the diagnosis of lung cancer.  bioAffinity’s cutting edge technique using cytometry to analyze sputum is the subject of the poster.

read more

bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.

 

www.thehealthcell.org/sitepage/state-of-the-industry/